Application number  =>  2472/CHENP/2012 A 

Date of filing of application number  =>  16/03/2012 

Publication date  =>  31/05/2013 

Title  =>  GLYCINE COMPOUND 

Name of applicant  =>  1)ASTELLAS PHARMA INC. 

Name of inventor  =>  1)YOSHIHARA, KOUSEI 2)SUZUKI, DAISUKE 3)YAMAKI, SUSUMU 4)KOGA, YUJI 5)SEKI, NORIO 6)FUJIYASU, JIRO 

International Classification  =>  C07C237/04 

Priority Doc No  =>  2009-214991 

International Application Number  =>  PCT/JP2010/065918 

International Publication Number  =>  WO 2011/034078A1 

Abstract  =>  The present invention provides a compound which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases. [Means for Solution] The present inventors have conducted intensive studies on a compound having a VAP-1 inhibitory activity, and as a result, they have found that a compound of the present invention or a salt thereof exhibits an excellent VAP-1 inhibitory activity and is useful for preventing and/or treating VAP-1-related diseases, in particular, diabetic nephropathy or diabetic macular edema, thereby completing the present invention. The present invention further relates to a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases, which comprises the compound of the present invention or a salt thereof, and an excipient. 

